Connection

John Colwell to Blood Glucose

This is a "connection" page, showing publications John Colwell has written about Blood Glucose.
Connection Strength

0.695
  1. Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 1998 Apr; 21(4):510-5.
    View in: PubMed
    Score: 0.116
  2. Forum Two: Unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996 Jan 01; 124(1 Pt 2):178-9.
    View in: PubMed
    Score: 0.099
  3. Effects of isoflurane anesthesia on glucose tolerance and insulin secretion in Yucatan minipigs. Lab Anim Sci. 1992 Dec; 42(6):579-81.
    View in: PubMed
    Score: 0.080
  4. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. J Clin Endocrinol Metab. 1984 Aug; 59(2):278-86.
    View in: PubMed
    Score: 0.045
  5. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care. 2000 Oct; 23(10):1478-85.
    View in: PubMed
    Score: 0.034
  6. Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 2000 Sep; 23(9):1316-20.
    View in: PubMed
    Score: 0.034
  7. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications. 1999 Sep-Dec; 13(5-6):307-13.
    View in: PubMed
    Score: 0.032
  8. Controlling type 2 diabetes: are the benefits worth the costs? JAMA. 1997 Nov 26; 278(20):1700.
    View in: PubMed
    Score: 0.028
  9. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Diabetes Care. 1996 Dec; 19(12):1375-81.
    View in: PubMed
    Score: 0.026
  10. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes. 1996 Jul; 45 Suppl 3:S87-90.
    View in: PubMed
    Score: 0.026
  11. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995 Aug; 18(8):1113-23.
    View in: PubMed
    Score: 0.024
  12. Is it time to introduce metformin in the U.S.? Diabetes Care. 1993 Apr; 16(4):653-5.
    View in: PubMed
    Score: 0.021
  13. Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM) Diabetes Care. 1992 Nov; 15(11):1560-71.
    View in: PubMed
    Score: 0.020
  14. Effect of insulin infusion of pancreas on blood glucose. Diabetes. 1966 Feb; 15(2):123-6.
    View in: PubMed
    Score: 0.012
  15. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33.
    View in: PubMed
    Score: 0.012
  16. QUANTITATIVE RELATIONSHIP BETWEEN PLASMA CONCENTRATION OF FATTY ACIDS AND GLUCOSE IN NORMAL AND DIABETIC DOGS. Diabetes. 1963 Sep-Oct; 12:424-8.
    View in: PubMed
    Score: 0.011
  17. EFFECT OF SITE OF ADMINISTRATION OF INSULIN ON BLOOD GLUCOSE AND FATTY ACID CONCENTRATIONS. Diabetes. 1963 Jul-Aug; 12:319-22.
    View in: PubMed
    Score: 0.010
  18. Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia. 1982 Jun; 22(6):430-6.
    View in: PubMed
    Score: 0.010
  19. Increased platelet arachidonic acid metabolism in diabetes mellitus. Diabetes. 1981; 30(Suppl 2):44-8.
    View in: PubMed
    Score: 0.009
  20. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM). Diabetes Care. 1998 Apr; 21(4):574-9.
    View in: PubMed
    Score: 0.007
  21. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med. 1997 Jan 27; 157(2):181-8.
    View in: PubMed
    Score: 0.007
  22. Effect of resection of adipose tissue on the diabetes and hyperinsulinism of benign symmetric lipomatosis. Diabetes. 1972 Jan; 21(1):13-5.
    View in: PubMed
    Score: 0.005
  23. Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia. Diabetes. 1971 Sep; 20(9):607-14.
    View in: PubMed
    Score: 0.005
  24. Pheochromocytoma and insulin. Ann Intern Med. 1969 Sep; 71(3):668-9.
    View in: PubMed
    Score: 0.004
  25. Inhibition of insulin secretion by catecholamines in pheochromocytoma. Ann Intern Med. 1969 Aug; 71(2):251-6.
    View in: PubMed
    Score: 0.004
  26. Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes. 1967 Aug; 16(8):560-5.
    View in: PubMed
    Score: 0.003
  27. Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia. 1986 Oct; 29(10):685-9.
    View in: PubMed
    Score: 0.003
  28. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics. Diabetes. 1983 Oct; 32(10):908-14.
    View in: PubMed
    Score: 0.003
  29. Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus. Thromb Res. 1980 Jan 1-15; 17(1-2):261-6.
    View in: PubMed
    Score: 0.002
  30. The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects. Clin Endocrinol (Oxf). 1977 Jun; 6(6):437-42.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.